InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-32.3%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by FLAVIN JOHN L, Director. Director active across 1 company, notably Pyxis Oncology, Inc.. Cumulatively, 4 reports have been recorded. History available since 31 March 2022. The latest transaction was disclosed on 26 March 2024 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations4 total
35,219 shares0Common StockSEC:0000950170-24-038104:0
139,355 shares0Common StockSEC:0001209191-23-021407:0
66,831 shares0Common StockSEC:0001140361-22-012921:0
2,388 sharesCommon StockSEC:0001140361-21-034643:0
4 of 4 declarations
About FLAVIN JOHN L
John L. Flavin is a Board Member at Pyxis Oncology, Inc. He plays an active role in the governance of the company, bringing his expertise in biotechnology and strategy. Flavin contributes to important decision-making and the strategic direction of Pyxis Oncology.
